Your partner in science for end-to-end CRDMO solutions
Leadership Team
Giuliano Perfetti
CEO & Managing Director
Giuliano has over 25 years of experience in the global pharmaceutical industry, focusing on Strategy, Organization, and Business Development.
He began his career in strategy consulting at Accenture, developing innovative go-to-market plans for pharmaceutical and industrial clients. He then moved to AstraZeneca, where he held leadership roles in Strategy & Business Development, Sales & Marketing, managing various franchises and gaining extensive industry experience.
In the CDMO sector, Giuliano contributed significantly to the growth and expansion of leading CDMO players such as Euticals and FIS, serving as Chief Commercial Officer and establishing several strategic collaborations with Big Pharma and Innovative companies.
Since 2019, Giuliano has been the Chairman of the European Innovation Committee and a Board Member at EFCG. Since 2021, he has served as the Official co-rapporteur for the European Innovation stream in the EU's dialogue on medicine supply security.
Since 2021, he has been the CEO and Managing Director of Jubilant Biosys, where he has led the transformation of the Drug Discovery and API units by creating a full-fledged CRDMO platform with 2,400 employees. He has focused on strong differentiation in innovation, particularly in Integrated Drug Discovery, and has driven expansion in fast-growing segments such as CDMO and emerging technologies.
He holds a postgraduate degree in Economics with a thesis in Financial Mathematics from the University of Tor Vergata in Rome and has completed management courses at INSEAD and Cranfield University. His career showcases his dedication to the pharmaceutical industry's innovation and growth
